Roles of CD4+ T cells as mediators of antitumor immunity.

Roles of CD4+ T cells as mediators of antitumor immunity.
复制标题

CD4+ T 细胞作为抗肿瘤免疫介质的作用。

DOI:
10.3389/fimmu.2022.972021
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

已经充分确定,CD8+ T细胞充当针对肿瘤的适应性免疫应答的效应细胞,而CD4+ T细胞帮助或抑制CD8+细胞毒性T细胞的产生。然而,在几个实验模型以及癌症患者中,已经显示CD4+ T细胞也可以通过直接杀死肿瘤细胞或间接通过激活先天免疫细胞或通过减少肿瘤血管生成来介导抗肿瘤免疫。在这篇综述中,我们讨论了越来越多的证据表明,这种低估的作用,CD4+ T细胞作为介质的抗肿瘤免疫。
It has been well established that CD8+ T cells serve as effector cells of the adaptive immune response against tumors, whereas CD4+ T cells either help or suppress the generation of CD8+ cytotoxic T cells. However, in several experimental models as well as in cancer patients, it has been shown that CD4+ T cells can also mediate antitumor immunity either directly by killing tumor cells or indirectly by activating innate immune cells or by reducing tumor angiogenesis. In this review, we discuss the growing evidence of this underappreciated role of CD4+ T cells as mediators of antitumor immunity.
DOI: 10.1084/jem.188.12.2357
发表时间: 1998-12-21
期刊: The Journal of experimental medicine
影响因子: --
作者:
Hung K;Hayashi R;Lafond-Walker A;Lowenstein C;Pardoll D;Levitsky H
通讯作者: Levitsky H
DOI: 10.1038/cddis.2017.125
发表时间: 2017-03-23
影响因子: 9
作者:
He K;Liu P;Xu LX
通讯作者: Xu LX
DOI: 10.1158/1078-0432.ccr-19-1321
发表时间: 2020-08-01
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Garris CS;Luke JJ
通讯作者: Luke JJ
DOI: 10.1056/nejmoa0800251
发表时间: 2008-06-19
影响因子: 158.5
作者:
Hunder, Naomi N.;Wallen, Herschel;Yee, Cassian
通讯作者: Yee, Cassian
DOI: 10.1007/s00262-012-1329-y
发表时间: 2013-02
影响因子: 5.8
作者:
Akhmetzyanova, Ilseyar;Zelinskyy, Gennadiy;Schimmer, Simone;Brandau, Sven;Altenhoff, Petra;Sparwasser, Tim;Dittmer, Ulf
通讯作者: Dittmer, Ulf